The May PV conference in Nairobi, hosted by USAID’s SIAPS Program and the Food and Drug Administration, has generated continued interest in patient safety and associated issues in Africa.
Please follow the link below to see Dr. Gerald Dal Pan, acting director for the Office of Surveillance and Epidemiology in FDA’s Center for Drug Evaluation and Research, highlight a recent example of FDA’s efforts to transform from a domestic to a truly global agency. He describes a meeting in Nairobi, Kenya, with the U.S. Agency for International Development (USAID) to share tools and best practices with African regulators on drug safety.
